医学
阿替唑单抗
卡铂
安慰剂
紫杉醇
肿瘤科
内科学
双盲
妇科
化疗
癌症
顺铂
免疫疗法
彭布罗利珠单抗
替代医学
病理
作者
Nicoletta Colombo,Kenichi Harano,Emma Hudson,Francesca Galli,Yoland Antill,Chel Hun Choi,Manuela Rabaglio,Frederik Marmé,Edgar Petru,Chien‐Hung Lai,Elena Biagioli,L. Fariñas Madrid,Kazuhiro Takehara,K. Allan,Y.C. Lee,Elisa Piovano,Claudio Zamagni,Giulia Tasca,Annamaria Ferrero,M.P. Barretina Ginesta
标识
DOI:10.1016/j.annonc.2023.10.034
摘要
The standard therapy for advanced/recurrent endometrial cancer includes carboplatin and paclitaxel (CP). Robust biological rationale suggested a synergy between immunotherapy and chemotherapy in this setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI